Not all Nervonic Acid is called “Bao Feng Nervonic Acid

• Date：2022-04-26

• By：Zhong Yuan Biotech

Not all Nervonic Acid is called “Bao Feng Nervonic Acid"!

Former Coca-Cola Chairman Robert Woodruff famously said, "Even if all the Coca-Cola factories in the world were burned down overnight, I could regain investment and bob up like a cork in a few months with the Coca-Cola trademark.

It has been over 130 years since Coca-Cola was born, what has kept its position intact?

This is the trademark gives Coca-Cola brand value of great energy, intellectual property rights is the hidden wealth of an enterprise.

According to the report "Global Innovation Index Report 2021" released by the World Intellectual Property Organization (WIPO), China ranked top in the number of IP innovations.

The innovation index in medical technology, pharmaceuticals and biotechnology hit a new high, with research institutions and enterprises such as the Chinese Academy of Sciences, Midea, Huawei and Gree all contributing significantly.

"Innovation is the first driving force leading development, and protecting intellectual property rights is protecting innovation." President Xi Jinping has stressed many times. After years of struggle, China's intellectual property business has continued to develop, becoming a veritable intellectual property power and laying a solid foundation for moving forward to an intellectual property power.

The fight against the epidemic cannot be separated from the support of science and technology, and "Healthy China" and "Innovative China" call for more and more valuable intellectual property rights, and more effective protection of intellectual property rights.

As an international leader in the field of brain health, with nearly 10 years of exploration and innovation, Baofeng Biotech has been working tirelessly on the road to overcome brain diseases! Since its establishment in 2012, Baofeng Biotech always insists on independent innovation, stimulates the innovation mechanism, focuses on the creation and protection of intellectual property rights, and continues to carry out technology research and development and patent protection.

Patented Nervonic Acid

Up to now, Bao Feng Biotech has accumulated 17 invention patents, 18 software copyrights and 4 PCT applications. Biomarker for Diagnosis of Cerebral White Matter Lesions and its Application" (Patent No. ZL202110352946.4) and "Biomarker F7 for Diagnosis of Cerebral White Matter Lesions and its Application" (Patent No. ZL202110385946.4) protect the screening markers for cerebral white matter disease including different molecular forms of Nervonic acid.

“Biomarkers for Diagnosing Cognitive Disorders and Their Applications” (Patent No. ZL202010816390.5) and “Biomarkers for Diagnosing Cognitive Disorders and Their Applications” (Patent No. 202010816217.5) protect screening markers for cognitive disorders, including sphingomyelin Nervonic Acid.

Biomarkers for Diagnosis of Nervonic Acid Onset in Acer Truncatum Oil and its Application" (Patent No. CN202010816389.2) protects core markers for diagnosis of nervonic acid onset. Molecular Markers for the Diagnosis of Ischemic and Hypoxic Encephalopathy with Nervonic Acid and its Application" (Patent No. CN2021110463527) and "Molecular Markers for the Diagnosis of Ischemic and Hypoxic Encephalopathy with Nervonic Acid and its Application in Plateau Environment" (Patent No. CN2021110463512) demonstrated that nervonic acid supplementation in HIE and plateau HIE patients can improve brain damage.

Biomarkers for Diagnosing Cerebral Infarction in Patients with Cerebral Leukoaraiosis and Their Applications" (Patent No. CN2021109998530) protects a combination of phosphatidylinositol as a core marker. Biomarkers for Diagnosing Cerebral Infarction in Patients with Cerebral Leukodystrophy and Their Applications" (Patent No. CN2021109998348) and "Biomarkers for Diagnosing Cerebral Infarction in Patients with Cerebral Leukodystrophy and Their Applications" (Patent No. CN202110999855X) both protect combinations with glucosyl ceramide (containing nervonic acid molecules) as the core marker. Biomarkers for Diagnosis of Cerebral Infarction and Cerebral Leukoaraiosis and Their Applications" (Patent No. CN2021109998634) protects the combination of galactose ceramide (containing nervonic acid molecules) as the core marker.

Not all Nervonic Acid is called “Bao Feng Nervonic Acid"!

All the Acer Truncatum Nervonic Acid samples used in the above patents are provided by Zhongyuan subsidiary Baofeng Biotechnology (Beijing) Ltd..

The chief scientist, researcher Xianyang Chen, led a team of Baofeng scientists to treat each product with scientific research spirit and attitude day and night, and jointly promote the process of brain disease screening and innovative drug development.

In 2021, the intellectual property owner delivered a perfect answer, with 530,000 granted invention patents and 69,000 PCT international patent applications. As a "unicorn company of comprehensive brain health solution", Baofeng Bio is leading the development of the whole nervonic acid industry, and is honored to contribute to this bright report card. But this is only the starting point of Baofeng Biotech, we will continue to insist on independent innovation, continue to develop technology and patent protection, and forge ahead on the road of neuroscience development!

Let's pay tribute to all the dedicated researchers.